1.
ARYx Therapeutics - ARYx Therapeutics, Inc. Announces Successful ...
Dec 18, 2008 ... ARYx Therapeutics, Inc. Announces Successful Outcome of Atrial Fibrillation Clinical Trial on ATI-2042. Clinical & Statistical Significance ...
2.
ARYx Therapeutics - Investor Relations
The ARYx mission is to make proven therapies safer. By applying its retrometabolic approach to pharmaceutical discovery and development, ARYx intends to ...
3.
ARYx Therapeutics - Press Releases
ARYx Therapeutics Inc. Completes Enrollment in EmbraceAC Study -- Phase 2/3 Clinical Trial Comparing Anticoagulant ATI-5923 Against Warfarin ...
4.
ARYx Therapeutics - ARYx Pharmaceuticals Names Sam L. Teichman, MD ...
ARYx Pharmaceuticals Names Sam L. Teichman, MD, As Chief Development Officer. Santa Clara, California - August 4, 2003 ARYx Therapeutics, Inc., a privately ...
5.
ARYx Therapeutics - Search Results
clinical trial for the treatment of Gastro-Esophogeal Reflux Disorder (GERD ... Apr 29, 2004, Releases, ARYx Therapeutics - ARYx Therapeutics Launches Phase ...
6.
7.
8.
9.
10.